Meridian Bioscience Inc MR4-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 05/27/22 CEST
24.15quote price arrow up+0.32 (+1.34%)
52 week range
14.44 - 25.60
Loading...
  • Open24.15
  • Day High24.15
  • Day Low24.15
  • Prev Close24.40
  • 52 Week High25.60
  • 52 Week High Date05/05/22
  • 52 Week Low14.44
  • 52 Week Low Date07/14/21

Key Stats

  • Market Cap1,214.48M
  • Shares Out43.56M
  • 10 Day Average Volume41.82
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change38.91

KEY STATS

  • Open24.15
  • Day High24.15
  • Day Low24.15
  • Prev Close24.40
  • 52 Week High25.60
  • 52 Week High Date05/05/22
  • 52 Week Low14.44
  • 52 Week Low Date07/14/21
  • Market Cap1,214.48M
  • Shares Out43.56M
  • 10 Day Average Volume41.82
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change38.91

RATIOS/PROFITABILITY

  • EPS (TTM)1.28
  • P/E (TTM)18.87
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/01/2019
  • Div Amount0.125
  • Split Date-
  • Split Factor-

Latest On Meridian Bioscience Inc

There is no recent news for this security.

Profile

MORE
Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain gastrointestinal and respiratory infectious diseases and elevated blood lead levels. The Company's segments include Diagnostics and Life Science. The Diagnostics segment consists of manufacturing operations for infectious disease products in Cincinnati, Ohio; Quebec City, Canada; and Modi' in, Israel....
John McIlwraith J.D.
Chairman of the Board
John Kenny
Chief Executive Officer, Director
Andrew Kitzmiller
Executive Vice President, Chief Financial Officer
Julie Smith
Chief Accounting Officer
Lourdes Weltzien
Executive Vice President - Life Science
Address
3471 River Hills Dr
Cincinnati, OH
45244
United States